Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 21.24 billion as of July 25, 2025. Its market cap has increased by 13.74% in one year.

Market Cap

21.24B

Enterprise Value

20.26B

Revenue

2.68B

Ranking

n/a

PE Ratio

161.27

Stock Price

12.86

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 21.24B, an increase of 55.77%. That is a compound annual growth rate of 3.06%.

Market Cap History

Date	Market Cap	% Change
Jul 23, 2025	18.52B	-4.14%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	383.74B
Shenzhen Mindray Bio-Medical Electronics	280.66B
WuXi AppTec	239.63B
Sichuan Biokin Pharmaceutical	124.35B
Zhangzhou Pientzehuang Pharmaceutical.,	124.16B
Aier Eye Hospital Group	118.61B
Shanghai United Imaging Healthcare	109.45B
Yunnan Baiyao Group Co.,Ltd	100.86B

Market Cap Rankings